AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Simulations Plus Sets Date for 2nd Quarter 2019 Earnings Release and Conference Call

April 2, 2019

LANCASTER, Calif.--(BUSINESS WIRE)--Apr 2, 2019--Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2019 fiscal year, the period ended February 28, 2019, on Tuesday, April 9, 2019.

The Company will host a conference call on April 9, 2019, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here. On registering, you will receive a confirmation e-mail with instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial (415) 930-5321, and enter access code 271-105-468. A replay will be available at the Simulations Plus website following the call.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at www.simulations-plus.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190402005312/en/

CONTACT: Simulations Plus Investor Relations

Ms. Renee Bouche

661-723-7723

renee@simulations-plus.comHayden IR

Mr. Cameron Donahue

651-653-1854

cameron@haydenir.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL COMMUNICATIONS PUBLIC RELATIONS/INVESTOR RELATIONS

SOURCE: Simulations Plus, Inc.

Copyright Business Wire 2019.

PUB: 04/02/2019 08:30 AM/DISC: 04/02/2019 08:30 AM

http://www.businesswire.com/news/home/20190402005312/en